VRT vs VRTX · P/E 80, rev $10.23B vs P/E 30, rev $12.00B
Vertiv Holdings Co (VRT) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Vertiv Holdings Co (VRT) is a electrical equipment & parts company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported VRT revenue for 2025-12-31 was $10.23B. Net income was $1.33B. Revenue was up 27.7% from 2024-12-31 to 2025-12-31. VRT currently screens at market cap $121.99B and trailing P/E 79.8.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
VRT currently screens at market cap $121.99B and trailing P/E 79.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the VRT and VRTX stock pages for the full models.
Not investment advice.